Apogee Therapeutics, Inc. - COMMON STOCK (APGE)
CUSIP: 03770N101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 61,257,262
- Total 13F shares
- 57,873,775
- Share change
- +1,971,570
- Total reported value
- $2,621,627,227
- Put/Call ratio
- 199%
- Price per share
- $45.30
- Number of holders
- 156
- Value change
- +$63,332,544
- Number of buys
- 83
- Number of sells
- 60
Quarterly Holders Quick Answers
What is CUSIP 03770N101?
CUSIP 03770N101 identifies APGE - Apogee Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03770N101:
Top shareholders of APGE - Apogee Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VR Adviser, LLC |
13F
|
Company |
14%
|
8,493,321
|
$498,897,676 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
12%
|
7,502,482
|
$440,695,792 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.9%
|
4,814,400
|
$282,797,855 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
4.9%
|
2,975,917
|
$174,805,365 | — | 30 Sep 2024 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
4.4%
|
2,712,096
|
$159,308,519 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.1%
|
2,533,607
|
$148,824,075 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
2,127,042
|
$124,942,448 | — | 30 Sep 2024 | |
| Fairmount Funds Management LLC |
13F
|
Company |
3.3%
|
2,048,647
|
$120,337,525 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.3%
|
2,015,007
|
$118,361,511 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.2%
|
1,961,863
|
$115,239,833 | — | 30 Sep 2024 | |
| BRAIDWELL LP |
13F
|
Company |
2.7%
|
1,643,226
|
$96,523,095 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.3%
|
1,411,639
|
$82,919,675 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.9%
|
1,194,363
|
$70,156,883 | — | 30 Sep 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
1.6%
|
1,000,000
|
$58,740,000 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.6%
|
976,155
|
$57,339,345 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
823,839
|
$48,400,893 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.4%
|
860,989
|
$48,051,796 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
758,081
|
$44,531,000 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
707,268
|
$41,544,893 | — | 30 Sep 2024 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
1.1%
|
701,817
|
$41,224,731 | — | 30 Sep 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1.1%
|
664,198
|
$39,014,991 | — | 30 Sep 2024 | |
| Waypoint Capital Advisors, LLC |
13F
|
Company |
1%
|
627,089
|
$36,835,208 | — | 30 Sep 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.77%
|
469,557
|
$27,586,474 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.62%
|
379,130
|
$22,270,096 | — | 30 Sep 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.6%
|
369,197
|
$21,686,632 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.6%
|
365,046
|
$21,442,803 | — | 30 Sep 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.57%
|
346,358
|
$20,345,070 | — | 30 Sep 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.51%
|
312,611
|
$18,362,771 | — | 30 Sep 2024 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.51%
|
311,316
|
$18,286,702 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
306,549
|
$18,006,688 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.49%
|
299,472
|
$17,590,985 | — | 30 Sep 2024 | |
| Commodore Capital LP |
13F
|
Company |
0.47%
|
290,000
|
$17,034,600 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
280,428
|
$16,472,341 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
238,270
|
$13,996,036 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.33%
|
199,308
|
$11,707,352 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.29%
|
179,000
|
$10,514,460 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
157,457
|
$9,249,025 | — | 30 Sep 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.25%
|
154,000
|
$9,045,960 | — | 30 Sep 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.22%
|
136,500
|
$8,018,010 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.22%
|
135,346
|
$7,950,225 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.22%
|
132,166
|
$7,763,431 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.18%
|
112,601
|
$6,614,179 | — | 30 Sep 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.18%
|
109,410
|
$6,426,743 | — | 30 Sep 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.18%
|
107,694
|
$6,325,946 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
100,000
|
$5,874,000 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.16%
|
98,290
|
$5,773,555 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.15%
|
93,446
|
$5,418,934 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.15%
|
91,757
|
$5,389,806 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.15%
|
90,009
|
$5,287,129 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.15%
|
90,000
|
$5,286,363 | — | 30 Sep 2024 |
Institutional Holders of Apogee Therapeutics, Inc. - COMMON STOCK (APGE) as of Q4 2024
As of 31 Dec 2024,
Apogee Therapeutics, Inc. - COMMON STOCK (APGE) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,873,775 shares.
The largest 10 holders included
VR Adviser, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., RTW INVESTMENTS, LP, Driehaus Capital Management LLC, VANGUARD GROUP INC, Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., and BRAIDWELL LP.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
137
Q4 2024 holders
156
Holder diff
19
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.